Scanning nano-spin ensemble microscope for nanoscale magnetic and thermal imaging

Quantum sensors based on solid-state spins provide tremendous opportunities in a wide range of fields from basic physics and chemistry to biomedical imaging. However, integrating them into a scanning probe microscope to enable practical, nanoscale quantum imaging is a highly challenging task. Recently, the use of single spins in diamond in conjunction with atomic force microscopy techniques has allowed significant progress towards this goal, but generalisation of this approach has so far been impeded by long acquisition times or by the absence of simultaneous topographic information. Here we report on a scanning quantum probe microscope which solves both issues, by employing a nano-spin ensemble hosted in a nanodiamond. This approach provides up to an order of magnitude gain in acquisition time, whilst preserving sub-100 nm spatial resolution both for the quantum sensor and topographic images. We demonstrate two applications of this microscope. We first image nanoscale clusters of maghemite particles through both spin resonance spectroscopy and spin relaxometry, under ambient conditions. Our images reveal fast magnetic field fluctuations in addition to a static component, indicating the presence of both superparamagnetic and ferromagnetic particles. We next demonstrate a new imaging modality where the nano-spin ensemble is used as a thermometer. We use this technique to map the photo-induced heating generated by laser irradiation of a single gold nanoparticle in a fluid environment. This work paves the way towards new applications of quantum probe microscopy such as thermal/magnetic imaging of operating microelectronic devices and magnetic detection of ion channels in cell membranes.Comment: 22 pages including Supporting Information. Changes to v1: affiliations and funding information updated, plus minor revisions to the main tex

Evaluation of component mode synthesis methods for the detection of modal interaction through rotor/stator contacts

International audienceThe study of interactions through direct contact between blade-tips and outer casings in modern turbomachines may be very time-consuming when the classical finite element method is used. The construction of reduced-order models using component mode synthesis methods generally allows for dramatic increase in computational efficiency and may be used in order to improve the knowledge over these interaction phenomena. Among the available approaches, both a fixed-interface method and a free-interface method are considered here in an original manner to reduce the size of a realistic two-dimensional model. The equations of motion are solved using an explicit time integration scheme with the Lagrange multiplier method where friction is accounted for. This method offers energy momentum conserving which is a critical point to ensure the convergence of the algorithm. Moreover, it is shown that even in a non-linear framework the reduced-order models converge to the finite element solution as the number of modes included in the models increases. Considering the fixed-interface method of Craig-Bampton and the free-interface method of Craig-Chang-Martinez, it is shown that a method with fast displacement convergence may be less efficient in terms of motion convergence

Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients

Background. End stage renal disease increases the risk of reactivating latent tuberculosis (LTBI). Interferon-γ release assays (IGRA) are an alternative to the tuberculin skin test (TST) for detecting LTBI. Methods. Sixty-two hemodialysis patients (46 male, 16 female, aged 65 ± 15 years) from 3 hemodialysis facilities in the Geneva area were submitted to a TST, 2 IGRA (T-SPOT.TB and QuantiFERON Gold in tube: QFT), a chest radiography, and a questionnaire to record social status, country of birth, history of prior TST, tuberculosis (TB), BCG (Bacillus of Calmette-Guérin vaccine), and any cause of immuno-suppression. LTBI was defined as prior "at risk” contact with a case of contagious TB and/or a chest X-ray suggestive of prior TB infection. Results. Positivity rate was 19% for TST, 21% for QFT and 29% for T-SPOT-TB; 8% of QFT and 11% of T-SPOT-TB were indeterminate. Agreement between IGRA was fair (κ= 0.60). After adjusting for age and BCG, OR (Odds Ratio) of having a positive QFT was 4.6-fold (p = 0.029) higher in patients with LTBI vs. those without LTBI. In contrast, no association was found between LTBI and having a positive T-SPOT.TB or a positive TST. As expected, there was a strong association between prior BCG vaccination and having a positive TST (OR 5.3, p = 0.017). QFT was the only test with a significant OR of having LTBI (adjusted OR: 4.4; 95%CI: 1.1 − 17.6; p = 0.034). Among 5 patients with definite prior TB, TST and T-SPOT.TB were positive in 1 and QFT, in 2. Conclusions. In this population, QFT was superior to TST for detecting LTBI, but both IGRAs and TST have important limitations, and are unreliable for screening for LTB

Coherent beam combining with an ultrafast multicore Yb-doped fiber amplifier

International audienceActive coherent beam combination using a 7-non-coupled core,polarization maintaining, air-clad, Yb-doped fiber is demonstrated as amonolithic and compact power-scaling concept for ultrafast fiber lasers. Amicrolens array matched to the multicore fiber and an active phasecontroller composed of a spatial light modulator applying a stochasticparallel gradient descent algorithm are utilized to perform coherentcombining in the tiled aperture geometry. The mitigation of nonlineareffects at a pulse energy of 8.9 μJ and duration of 860 fs is experimentallyverified at a repetition rate of 100 kHz. The experimental combiningefficiency results in a far field central lobe carrying 49% of the total power,compared to an ideal value of 76%. This efficiency is primarily limited bygroup delay differences between cores which is identified as the maindrawback of the system. Minimizing these group delay issues, e.g. by usingshort and straight rod-type multicore fibers, should allow a practical powerscaling solution for femtosecond fiber systems

Immature and mature bone marrow-derived dendritic cells exhibit distinct intracellular mechanical properties

ABSTRACT: Dendritic cells (DCs) patrol the organism at an immature stage to detect the presence of pathogens. Once activated, these mature DCs reach the lymph nodes to activate antigen-specific T lymphocytes and thus initiate an adaptative immune response to control the pathogen. The migration of both immature and mature DCs is a key process for their optimal function. DC migration requires transit through narrow constrictions that is allowed by their high local and global deformation capabilities. In addition to cytoplasmic changes, the nucleus mechanical properties also have a major impact for cellular migration and motility. Yet, nucleus intracellular mobility of dendritic cells or its variation upon maturation have not been investigated. Our study defines the biophysical phenotypic variations of dendritic cells upon maturation using interferometric deformability cytometry. This method characterizes different cellular mechanical properties, such as elongation and nucleus offset, by assessing the refractive index spatial distribution of shear-induced deformed cells. By using these parameters, our data suggest that in vitro bone marrow derived dendritic cell (BMDC) maturation induces cell stiffening and reduces nucleus mobility, allowing to distinguish immature and mature dendritic cells. Overall, our method provides insights on intracellular mechanical properties of two dendritic cell states

Fungal systematics and evolution : FUSE 1

Fungal Systematics and Evolution (FUSE) is introduced as a new series to expedite the publication of issues relating to the epitypification of formerly described species, report new sexual-asexual connections, the merging of sexual and asexual genera following the end of dual nomenclature, and to describe species or note interesting observations regarding fungi. This first paper includes 18 new combinations, 13 new species, three new genera and one new family. All taxa are ascomycetes, except one novel species, which is a basidiomycete. Based on its acervular conidioma, Septoria capensis is allocated to the genus Acervuloseptoria (Mycosphaerellaceae, Capnodiales, Dothideomycetes). Cheirospora botryospora is shown to have a Phialophora synasexual morph, and to belong to the Helotiales (Leotiomycetes). The genus Circinotrichum (Xylariaceae, Xylariales) is shown to be paraphyletic, and in need of revision. Dictyochaeta triseptata (Chaetosphaeriaceae, Chaetosphaeriales, Sordariomycetes) is reported on Eucalyptus twigs from Malaysia, and shown to have a microconidial morph. Pseudodinemasporium fabiforme (Chaetosphaeriaceae, Chaetosphaeriales, Sordariomycetes) is reported from leaf spots on Acacia mangium from Malaysia, and Sclerostagonospora cycadis (Phaeosphaeriaceae, Pleosporales, Dothideomycetes) on leaves of Dioscorea composita from Mexico. Novel taxa include: Asperisporium caricicola (Mycosphaerellaceae, Capnodiales, Dothideomycetes) from Carica papaya (Fiji), Coniella peruensis (Schizoparmaceae, Diaporthales, Sordariomycetes) from soil (Peru), Curreya acacia (Cucurbitariaceae, Pleosporales, Dothideomycetes) from Acacia mangium (Malaysia), Verrucoconiothyrium nitidae gen. nov. (Didymosphaeriaceae, Pleosporales, Dothideomycetes) from Proteaceae (South Africa), Cyphellophoriella pruni gen. et sp. nov. (Chaetothyriaceae, Chaetothyriales, Eurotiomycetes) from Prunus leaves (USA), Mycotribulus indonesiae (Physalacriaceae, Agaricales) from Eucalyptus leaves (Indonesia), Myrmecridium spartii (Myrmecridiaceae, Myrmecridiales, Sordariomycetes) and Diaporthe spartinicola (Diaporthaceae, Diaporthales, Sordariomycetes) from Spartium junceum (Spain), Neodevriesia poagena (Neodevriesiaceae, Capnodiales, Dothideomycetes) on stems of Poa sp. (the Netherlands). Novel taxa from Germany include: Dothiorella ulmacea (Botryosphaeriaceae, Botryosphaeriales, Dothideomycetes) from Ulmus laevis, Eleutheromyces pseudosubulatus (incertae sedis, Helotiales) from Lactarius scrobiculatus, Paracamarosporium fagi (Didymosphaeriaceae, Pleosporales, Dothideomycetes) from Fagus sylvatica, Phaeoisaria loranthacearum (incertae sedis, Sordariomycetes) from Loranthus europaeus, and Flammocladiella aceris gen. et sp. nov. (Flammocladiellaceae fam. nov., Hypocreales) from Acer platanoides. An epitype is designated for Phomatospora striatigera (incertae sedis, Sordariomycetes) from Typha angustifolia (France).http://www.sydowia.at/syd62-1/syd62-1.htmam2016Microbiology and Plant Patholog

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

Minimal information for studies of extracellular vesicles 2018 (MISEV2018):a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points

Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review

BACKGROUND:Sub-Saharan African (SSA) countries are experiencing rapid transitions with increased life expectancy. As a result the burden of age-related conditions such as neurodegenerative diseases might be increasing. We conducted a systematic review of published studies on common neurodegenerative diseases, and HIV-related neurocognitive impairment in SSA, in order to identify research gaps and inform prevention and control solutions. METHODS: We searched MEDLINE via PubMed, 'Banque de Donnees de Sante Publique' and the database of the 'Institut d'Epidemiologie Neurologique et de Neurologie Tropicale' from inception to February 2013 for published original studies from SSA on neurodegenerative diseases and HIV-related neurocognitive impairment. Screening and data extraction were conducted by two investigators. Bibliographies and citations of eligible studies were investigated. RESULTS: In all 144 publications reporting on dementia (n=49 publications, mainly Alzheimer disease), Parkinsonism (PD, n=20), HIV-related neurocognitive impairment (n=47), Huntington disease (HD, n=19), amyotrophic lateral sclerosis (ALS, n=15), cerebellar degeneration (n=4) and Lewy body dementia (n=1). Of these studies, largely based on prevalent cases from retrospective data on urban populations, half originated from Nigeria and South Africa. The prevalence of dementia (Alzheimer disease) varied between <1% and 10.1% (0.7% and 5.6%) in population-based studies and from <1% to 47.8% in hospital-based studies. Incidence of dementia (Alzheimer disease) ranged from 8.7 to 21.8/1000/year (9.5 to 11.1), and major risk factors were advanced age and female sex. HIV-related neurocognitive impairment's prevalence (all from hospital-based studies) ranged from <1% to 80%. Population-based prevalence of PD and ALS varied from 10 to 235/100,000, and from 5 to 15/100,000 respectively while that for Huntington disease was 3.5/100,000. Equivalent figures for hospital based studies were the following: PD (0.41 to 7.2%), ALS (0.2 to 8.0/1000), and HD (0.2/100,000 to 46.0/100,000). CONCLUSIONS: The body of literature on neurodegenerative disorders in SSA is large with regard to dementia and HIV-related neurocognitive disorders but limited for other neurodegenerative disorders. Shortcomings include few population-based studies, heterogeneous diagnostic criteria and uneven representation of countries on the continent. There are important knowledge gaps that need urgent action, in order to prepare the sub-continent for the anticipated local surge in neurodegenerative diseases